• SELECT CONDITION
    • Moderate-to-Severe Eczema (Ages 6+ Months)
    • Moderate-to-Severe Asthma (Ages 6+ Years)
    • Chronic Obstructive Pulmonary Disease
      (Ages 18+ Years)
    • Chronic Rhinosinusitis with Nasal Polyps
      (Ages 12+ Years)
    • Eosinophilic Esophagitis (Ages 1+ Years,
      who weigh at least 33 lb (15 kg))
    • Prurigo Nodularis (Ages 18+ Years)
    • Chronic Spontaneous Urticaria (Ages 12+ Years)
  • Choose Your
    Language
    • Español
    • Página de inicio de franquicias
    • Eczema moderado a grave (6 meses de edad o más)
    • Asma moderada a grave (6 años de edad o más)
    • Rinosinusitis crónica con pólipos nasales (12 años de edad o más)
    • 中文
    • 中文網站
  • Prescribing & Patient
    Information
    • PATIENT INFORMATION
    • Patient Information - English
    • Patient Information - Spanish
    • PRESCRIBING INFORMATION
    • Prescribing Information - English
    • Prescribing Information - Spanish
    • PRE-FILLED SYRINGE INSTRUCTIONS FOR USE
    • 200 mg Syringe - English
    • 200 mg Syringe - Spanish
    • 300 mg Syringe - English
    • 300 mg Syringe - Spanish
    • PRE-FILLED PEN INSTRUCTIONS FOR USE
    • 200 mg Pen - English
    • 200 mg Pen - Spanish
    • 300 mg Pen - English
    • 300 mg Pen - Spanish
  • For Healthcare
    Professionals
  • Copay
    Offer
  • FOR U.S. RESIDENTS ONLY
Dupixent® (dupilumab) Injection (200 mg or 300 mg) Logo
  • PATIENT SUPPORT,
    COST & SAVINGS
    • Copay Card
    • Pricing and Insurance
    • Patient Support Program
  • Taking
    Dupixent
    • Injection Support Center
    • Traveling With DUPIXENT
  • FREQUENTLY
    ASKED QUESTIONS
  • CHOOSE YOUR LANGUAGE
    • Español
    • Página de inicio de franquicias
    • Eczema moderado a grave
      (6 meses de edad o más)
    • Asma moderada a grave
      (6 años de edad o más)
    • Rinosinusitis crónica con pólipos nasales
      (12 años de edad o más)
    • 中文
    • 中文網站
  • For Healthcare Professionals
  • Copay Offer